Further, the levels of TSHR-Ab in subjects with a recent-onset, untreated GO are directly correlated with the clinical activity of the disease, confirming a potential role of these antibodies in the pathogenesis of GO [19]. The gene discussed is TSHR; the disease is geroderma osteodysplastica.